These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 25642111)

  • 21. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.
    Berman RM; Fava M; Thase ME; Trivedi MH; Swanink R; McQuade RD; Carson WH; Adson D; Taylor L; Hazel J; Marcus RN
    CNS Spectr; 2009 Apr; 14(4):197-206. PubMed ID: 19407731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. When is antidepressant polypharmacy appropriate in the treatment of depression?
    Si T; Wang P
    Shanghai Arch Psychiatry; 2014 Dec; 26(6):357-9. PubMed ID: 25642110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care.
    Warden D; Trivedi MH; Carmody T; Toups M; Zisook S; Lesser I; Myers A; Kurian KR; Morris D; Rush AJ
    J Psychiatr Pract; 2014 Mar; 20(2):118-32. PubMed ID: 24638046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing antidepressant treatment patterns in older and younger adults: a claims database analysis.
    Sanglier T; Saragoussi D; Milea D; Auray JP; Valuck RJ; Tournier M
    J Am Geriatr Soc; 2011 Jul; 59(7):1197-205. PubMed ID: 21718261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic review of treatments for refractory depression in older people.
    Cooper C; Katona C; Lyketsos K; Blazer D; Brodaty H; Rabins P; de Mendonça Lima CA; Livingston G
    Am J Psychiatry; 2011 Jul; 168(7):681-8. PubMed ID: 21454919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prescription patterns of antidepressants: findings from a US claims database.
    Milea D; Verpillat P; Guelfucci F; Toumi M; Lamure M
    Curr Med Res Opin; 2010 Jun; 26(6):1343-53. PubMed ID: 20373875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic options for treatment-resistant depression.
    Shelton RC; Osuntokun O; Heinloth AN; Corya SA
    CNS Drugs; 2010 Feb; 24(2):131-61. PubMed ID: 20088620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. National trends in psychotropic medication polypharmacy in office-based psychiatry.
    Mojtabai R; Olfson M
    Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polypharmacy prevalence rates in the treatment of unipolar depression in an outpatient clinic.
    Glezer A; Byatt N; Cook R; Rothschild AJ
    J Affect Disord; 2009 Sep; 117(1-2):18-23. PubMed ID: 19103462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
    McGrath PJ; Stewart JW; Fava M; Trivedi MH; Wisniewski SR; Nierenberg AA; Thase ME; Davis L; Biggs MM; Shores-Wilson K; Luther JF; Niederehe G; Warden D; Rush AJ
    Am J Psychiatry; 2006 Sep; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Provide optimized antidepressant monotherapy with multiple drugs before considering antidepressant polypharmacy.
    Saah T; Garlow SJ; Rapaport MH
    Shanghai Arch Psychiatry; 2014 Dec; 26(6):360-2. PubMed ID: 25642111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis.
    Iovieno N; Papakostas GI
    J Clin Psychiatry; 2012 Oct; 73(10):1300-6. PubMed ID: 23140647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medication options in the treatment of treatment-resistant depression.
    Pridmore S; Turnier-Shea Y
    Aust N Z J Psychiatry; 2004 Apr; 38(4):219-25. PubMed ID: 15038800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine. Fibromyalgia, chronic fatigue syndrome, migraine, irritable bowel syndrome, atypical facial pain, and premenstrual dysphoric disorder.
    Gruber AJ; Hudson JI; Pope HG
    Psychiatr Clin North Am; 1996 Jun; 19(2):351-69. PubMed ID: 8827194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy, safety and tolerability of Symbyax for acute-phase management of treatment-resistant depression.
    Bobo WV; Shelton RC
    Expert Rev Neurother; 2010 May; 10(5):651-70. PubMed ID: 20420487
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.